Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METEOR: Tolvaptan in Heart Failure
NCT00043758Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Jul 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Tolvaptan with Placebo (2 arms). Primary endpoint: Change in Left Ventricular End-Diastolic Volume at 52 weeks. Started Jul 2002; status: completed.
02
Drugs
tolvaptan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00043758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043758.